News
We report a case of severe hemorrhagic cystitis complicating high-dose cyclophosphamide (CY), total body irradiation and allogeneic hematopoietic stem cell transplantation (HSCT). Supportive care ...
1y
Verywell Health on MSNCystitis and Bladder Inflammation in Females and Males - MSNMedically reviewed by Robert Burakoff, MDMedically reviewed by Robert Burakoff, MD Cystitis is inflammation of your bladder ...
Key Milestones in Hemorrhagic Cystitis Treatment. Looking Ahead: Phase 2b Trial in 2025 The company is set to initiate a larger Phase 2b trial for LP-10 in the first half of 2025.
Matinas Biopharma Holdings, Inc. MTNB shares are trading higher on Wednesday after the company announced complete clinical resolution of a patient's recurrent hemorrhagic cystitis following ...
10mon
Verywell Health on MSNBladder Wall Thickening: What You Need to Know - MSNBladder wall thickening can happen as part of a number of conditions, such as UTI/cystitis, noncancerous tissue growths, ...
Pelvic Cancer Induced Hemorrhagic Cystitis Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Co Tuesday, 02 January 2024 12:17 GMT عربي ...
Lipella Pharmaceuticals advances hemorrhagic cystitis treatment. PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ: LIPO), a clinical-stage biotech firm, announced today its plans to launch a ...
(RTTNews) - Biotechnology company Lipella Pharmaceuticals Inc. (LIPO) announced top line results for its recently completed Phase 2a clinical trial evaluating the safety and efficacy of its drug ...
In hemorrhagic cystitis, the bladder lining becomes inflamed and starts to bleed. ... Treatment for interstitial cystitis involves lifestyle changes, supportive therapies, ...
NEW YORK, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView presents an exclusive Q&A with Dr. Michael Chancellor, Co-founder and Chief Medical Officer of Lipella Pharmaceuticals, Inc. (Nasdaq ...
PITTSBURGH - Lipella Pharmaceuticals Inc. (NASDAQ: LIPO), a clinical-stage biotech firm, announced today its plans to launch a Phase 2b clinical trial for LP-10, a potential treatment for hemorrhagic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results